ALS Limited secures full ownership of Nuvisan Pharma March 25, 2024 SYDNEY, AUSTRALIA: ALS Limited (ASX: ALQ) has announced the acquisition of the remaining 51% stake in Nuvisan Pharma Holding GmbH, a leading European contract research...